Syra Health Corp is filing for an IPO. The Carmel, Indiana company sells healthcare services and tech—health education, population health, behavioral health, workforce, digital health—aimed at prevent

Risks to know: government and state agency contracts (Indiana, Minnesota, Tennessee, Alabama, D.C.) tie revenue to public-sector budgets and procurement. It's also an emerging growth company, with reduced reporting requirements that may turn off some investors. Use of proceeds wasn't detailed in what we reviewed—so no assumptions there. What we do know: no long-term debt and about $2.4M in cash at year-end 2024, a relatively lean balance sheet going into a listing. The story: 2024 revenue of $8.0M, up 45% YoY, Population Health more than doubled, Q4 net losses nearly halved, and a first profitable quarter in Q1 2026. New CEO Gregory R. Alexander took over January 5, 2026, succeeding founder Dr. Deepika Vuppalanchi. Bottom line: real top-line growth and a path toward profitability, but micro-cap healthcare IPOs tied to government contracts carry thin margins for error. Watch contract concentration and whether the profit trend holds.

Risks to know: government and state agency contracts (Indiana, Minnesota, Tennessee, Alabama, D.C.) tie revenue to public-sector budgets and procurement. It's also an emerging growth company, with red